APDQX
Price
$16.62
Change
-$0.07 (-0.42%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

APDQX vs VMVAX

Header iconAPDQX vs VMVAX Comparison
Open Charts APDQX vs VMVAXBanner chart's image
Artisan Mid Cap Value Advisor
Price$16.62
Change-$0.07 (-0.42%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
APDQX vs VMVAX Comparison Chart
Loading...
VS
APDQX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APDQX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. APDQX (1.18B). VMVAX pays higher dividends than APDQX: VMVAX (2.14) vs APDQX (0.71). APDQX was incepted earlier than VMVAX: APDQX (9 years) vs VMVAX (13 years). APDQX is a more actively managed with annual turnover of: 27.81 vs. VMVAX (22.00). VMVAX has a lower initial minimum investment than APDQX: VMVAX (3000) vs APDQX (250000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. APDQX (1.15). VMVAX return over 5 years is better than : 48.82 vs. APDQX (-13.57).
APDQXVMVAXAPDQX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years13 years-
Gain YTD7.85214.94653%
Front LoadN/AN/A-
Min. Initial Investment25000030008,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.18B30.5B4%
Annual Yield % from dividends0.712.1433%
Returns for 1 year1.1525.355%
Returns for 3 years-25.2320.71-122%
Returns for 5 years-13.5748.82-28%
Returns for 10 yearsN/A100.88-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio